In Utero TCDD Programming for Mammary Cancer

乳腺癌子宫内 TCDD 编程

基本信息

  • 批准号:
    6740247
  • 负责人:
  • 金额:
    $ 14.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2003
  • 资助国家:
    美国
  • 起止时间:
    2003-04-18 至 2006-03-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): We have demonstrated that in utero exposure of rats to 2,3,7,8 tetrachlorodibenzo-p-dioxin (TCDD) suppresses the development of chemically induced mammary cancer in the adult female offspring. We have shown that mammary gland maturation accounts for the cellular mechanism of mammary cancer susceptibility. However, little is known about the underlying mechanisms at the genome and protein levels. We hypothesize that in utero exposure to TCDD acts via imprinting mechanism to alter the mammary gland proteome that in turn determines cancer susceptibility. The Specific Aim 1 is to investigate DNA methylation as imprinting mechanism of in utero TCDD exposure predisposing for mammary cancer susceptibility. From mammary glands of prepubertal and adult rats exposed in utero + TCDD, we will investigate DNA methyltransferases (Dnmts) and DNA base methylation of specific genes containing large CpG rich promoter regions. Hypermethylation is associated with gene silencing. We will focus our attention on estrogen receptor alpha (ER-alpha), glutathione S transferase-pi (GST-pi) and mammary derived growth inhibitor (MDGI). The protein products of these genes have been associated with the early stages of mammary cancer development. Aim 2 is to identify proteins that are differentially expressed in mammary glands of rats exposed in utero to TCDD Characterization of proteins that are differentially expressed during the period of mammary gland differentiation (day 21) and at time of carcinogen exposure (day 50) in the DMBA-rat model (in the absence of the original chemical modulator, TCDD) will identify proteins that predetermine mammary cancer susceptibility. We will identify differentially expressed proteins from mammary glands using 2-D gel electrophoresis and MALDI-TOF spectrometry Identification of methylated gene promoters and individual proteins/protein clusters that are differentially expressed will aid in understanding how in utero exposure to environmental chemicals can program predisposition for cancer.
描述(由申请人提供):我们已经证明,在将大鼠暴露于2,3,7,8四氯迪本佐-P-二恶英(TCDD)中,可以抑制成年女性后代化学诱导的乳腺癌的发展。我们已经表明,乳腺成熟是乳腺癌易感性的细胞机制。然而,对于基因组和蛋白质水平下的基本机制知之甚少。 我们假设在子宫中暴露于TCDD的行动是通过印记机制改变乳腺蛋白质组的,而乳腺蛋白质组反过来决定了癌症的易感性。具体目的1是将DNA甲基化作为子宫TCDD暴露于乳腺癌易感性的烙印机制。在暴露于子宫内 + TCDD中的青春期前和成年大鼠的乳腺中,我们将研究DNA甲基转移酶(DNMTS)和含有大型CPG富启动子区域的特定基因的DNA碱基甲基化。高甲基化与基因沉默有关。我们将注意力集中在雌激素受体α(ER-Alpha),谷胱甘肽转移酶-PI(GST-PI)和乳腺衍生的生长抑制剂(MDGI)上。这些基因的蛋白质产物与乳腺癌发展的早期阶段有关。 Aim 2 is to identify proteins that are differentially expressed in mammary glands of rats exposed in utero to TCDD Characterization of proteins that are differentially expressed during the period of mammary gland differentiation (day 21) and at time of carcinogen exposure (day 50) in the DMBA-rat model (in the absence of the original chemical modulator, TCDD) will identify proteins that predetermine mammary cancer敏感性。我们将使用2-D凝胶电泳和MALDI-TOF光谱法鉴定甲基化基因启动子和单个蛋白质/蛋白簇的鉴定,这些蛋白质将鉴定出乳腺中差异表达的蛋白质,这些蛋白质差异表达,这些蛋白质蛋白会有助于理解子宫内对环境化学物质在环境化学物质中如何在环境化学物质中如何为癌症编程。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CORAL LAMARTINIERE其他文献

CORAL LAMARTINIERE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CORAL LAMARTINIERE', 18)}}的其他基金

Genomic and Proteomic Biomarkers of Biological Responses to Exposure
暴露生物反应的基因组和蛋白质组生物标志物
  • 批准号:
    7337765
  • 财政年份:
    2007
  • 资助金额:
    $ 14.5万
  • 项目类别:
In Utero Mammary Cancer Risk with Resveratrol and TCDD
白藜芦醇和 TCDD 的子宫内乳腺癌风险
  • 批准号:
    7416603
  • 财政年份:
    2007
  • 资助金额:
    $ 14.5万
  • 项目类别:
Genomic and Proteomic Biomarkers of Biological Responses to Exposure
暴露生物反应的基因组和蛋白质组生物标志物
  • 批准号:
    7849080
  • 财政年份:
    2007
  • 资助金额:
    $ 14.5万
  • 项目类别:
In Utero Mammary Cancer Risk with Resveratrol and TCDD
白藜芦醇和 TCDD 的子宫内乳腺癌风险
  • 批准号:
    7240202
  • 财政年份:
    2007
  • 资助金额:
    $ 14.5万
  • 项目类别:
Genomic and Proteomic Biomarkers of Biological Responses to Exposure
暴露生物反应的基因组和蛋白质组生物标志物
  • 批准号:
    7485238
  • 财政年份:
    2007
  • 资助金额:
    $ 14.5万
  • 项目类别:
Genomic and Proteomic Biomarkers of Biological Responses to Exposure
暴露生物反应的基因组和蛋白质组生物标志物
  • 批准号:
    7647768
  • 财政年份:
    2007
  • 资助金额:
    $ 14.5万
  • 项目类别:
Genomic and Proteomic Biomarkers of Biological Responses to Exposure
暴露生物反应的基因组和蛋白质组生物标志物
  • 批准号:
    7627364
  • 财政年份:
    2007
  • 资助金额:
    $ 14.5万
  • 项目类别:
In Utero TCDD Programming for Mammary Cancer
乳腺癌子宫内 TCDD 编程
  • 批准号:
    6648223
  • 财政年份:
    2003
  • 资助金额:
    $ 14.5万
  • 项目类别:
In Utero TCDD Programming for Mammary Cancer
乳腺癌子宫内 TCDD 编程
  • 批准号:
    6876160
  • 财政年份:
    2003
  • 资助金额:
    $ 14.5万
  • 项目类别:
Genistein Impriting Against Prostate Cancer
金雀异黄素抑制前列腺癌
  • 批准号:
    6642674
  • 财政年份:
    2001
  • 资助金额:
    $ 14.5万
  • 项目类别:

相似国自然基金

解毒三根汤基于β-catenin/ZEB1逆转AKT抑制剂诱导AKT1 E17K突变乳腺癌EMT的协同增效机制研究
  • 批准号:
    82305336
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于磁共振APT成像的乳腺癌新辅助治疗敏感性预测研究
  • 批准号:
    82302153
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
海洋来源二倍半萜MHO7靶向整合素β8/TGF-β轴调控EMT抑制三阴性乳腺癌转移的作用机制研究
  • 批准号:
    82304550
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
SGK3/BECN1信号促进自噬介导乳腺癌对他莫昔芬耐药机制研究
  • 批准号:
    82373901
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
调控线粒体钙失稳纳米信使联合自噬抑制用于乳腺癌的信号级联可视化治疗研究
  • 批准号:
    82302210
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Core 1: Biostatistics & Bioinformatics Core
核心1:生物统计学
  • 批准号:
    10716157
  • 财政年份:
    2023
  • 资助金额:
    $ 14.5万
  • 项目类别:
Blockade of cMYC oncogenic function by pregnancy-induced alterations and remodeling of the mammary gland
通过妊娠引起的乳腺改变和重塑来阻断 cMYC 致癌功能
  • 批准号:
    10734182
  • 财政年份:
    2023
  • 资助金额:
    $ 14.5万
  • 项目类别:
Landscape and characterization of promoter mutations driving triple-negative breast cancer
驱动三阴性乳腺癌的启动子突变的景观和特征
  • 批准号:
    10751219
  • 财政年份:
    2023
  • 资助金额:
    $ 14.5万
  • 项目类别:
Long-Term Trajectories of Accelerated Biological Aging and Functional Decline Associated with Breast Cancer and its Treatment
与乳腺癌及其治疗相关的加速生物衰老和功能衰退的长期轨迹
  • 批准号:
    10729432
  • 财政年份:
    2023
  • 资助金额:
    $ 14.5万
  • 项目类别:
Hawaii Minority Health and Cancer Disparities SPORE
夏威夷少数民族健康与癌症差异 SPORE
  • 批准号:
    10716152
  • 财政年份:
    2023
  • 资助金额:
    $ 14.5万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了